• Diagnosis​ Info ​and​ ​General​ ​Questions

  GBT to Request That Oxbryta Treat SCD Children Starting at Age 4

  Posted by Sickle Cell Forum Administrator on June 18, 2020 at 9:15 am

  

  GBT plans to file a request with the FDA in mid-2021 asking that Oxbryta treat SCD patients ages 4 to 11, and two pediatric global trials are recruiting. Learn more here.

  What do you think of this news?

  Sickle Cell Forum Administrator replied 3 years, 11 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply